Sorry, you need to enable JavaScript to visit this website.

A Study to Collect Information on Etanercept Manufactured Using a New High Capacity Process in Rheumatoid Arthritis Patients

A Single-Arm, Open-Label Study to Assess the Immunogenicity, Safety, and Efficacy of Etanercept Manufactured Using the High Capacity Process Administered to Subjects With Rheumatoid Arthritis

Category & Conditions: Immune System Diseases and Conditions
Medicine: Enbrel®/Etanercept
ClinicalTrials.gov Identifier (NCT): NCT02378506
Protocol ID: B1801359
    Share
PrintDownload
Open Plain Language Summary Result: Click here